US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 33.950
  • +0.480+1.43%
Close Nov 25 16:00 ET
  • 33.950
  • 0.0000.00%
Post 16:16 ET
2.30BMarket Cap-29267P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.82%-15.92M
-49.45%-16.12M
-225.72%-26.01M
-53.26%-45.68M
-114.45%-14.65M
-12.26M
-10.79M
-7.99M
-118.28%-29.8M
-6.83M
Net income from continuing operations
-73.39%-20.41M
-62.73%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-97.27%-16.56M
---11.77M
---11.62M
---8.67M
-176.06%-35.44M
---8.39M
Depreciation and amortization
320.00%21K
75.00%7K
0.00%4K
13.33%17K
0.00%4K
--5K
--4K
--4K
50.00%15K
--4K
Other non cash items
-106.25%-4K
-101.61%-10K
-102.40%-3K
60.90%819K
-91.59%9K
--64K
--621K
--125K
26.62%509K
--107K
Change In working capital
1,644.62%3.4M
951.40%3.01M
-2,351.74%-8.4M
-22.53%3.44M
98.24%2.59M
--195K
--286K
--373K
325.67%4.44M
--1.3M
-Change in receivables
4,600.00%45K
----
----
----
----
---1K
----
----
----
----
-Change in prepaid assets
76.84%-431K
327.87%1.21M
-2,624.11%-5.65M
-353.77%-2.72M
-178.06%-555K
---1.86M
---531K
--224K
153.76%1.07M
--711K
-Change in payables and accrued expense
85.32%3.79M
131.09%1.89M
-1,920.13%-2.71M
85.55%6.15M
429.34%3.14M
--2.04M
--817K
--149K
2,807.02%3.31M
--593K
-Change in other current assets
--0
---1K
---33K
-75.00%13K
--0
--13K
--0
--0
161.18%52K
--0
Cash from discontinued investing activities
Operating cash flow
-29.82%-15.92M
-49.45%-16.12M
-225.72%-26.01M
-53.26%-45.68M
-114.45%-14.65M
---12.26M
---10.79M
---7.99M
-118.28%-29.8M
---6.83M
Investing cash flow
Cash flow from continuing investing activities
119.83%32.01M
-135.05%-36.23M
-290.66%-307.44M
-118.95%-121.2M
128.07%15.53M
-161.39M
103.36M
-78.7M
-56,963.92%-55.35M
-55.34M
Net PPE purchase and sale
-83.33%1K
-133.33%-14K
---12K
--0
--0
--6K
---6K
--0
85.57%-14K
--1K
Net investment purchase and sale
119.83%32M
-135.04%-36.22M
-290.64%-307.43M
-119.01%-121.2M
128.07%15.53M
---161.39M
--103.36M
---78.7M
---55.34M
---55.34M
Cash from discontinued investing activities
Investing cash flow
119.83%32.01M
-135.05%-36.23M
-290.66%-307.44M
-118.95%-121.2M
128.07%15.53M
---161.39M
--103.36M
---78.7M
-56,963.92%-55.35M
---55.34M
Financing cash flow
Cash flow from continuing financing activities
-97.95%2.17M
100.26%40K
52,735.03%402.66M
-27.32%87M
-105.11%-2.9M
105.88M
-15.23M
-765K
674.91%119.69M
56.7M
Net issuance payments of debt
--0
--0
56.18%-365K
---16.29M
---7K
---61K
---15.39M
---833K
--0
--0
Net common stock issuance
--0
--0
--406.41M
----
----
--0
--0
--0
----
----
Net preferred stock issuance
----
----
----
-12.47%104.63M
--0
----
----
----
--119.53M
--56.55M
Proceeds from stock option exercised by employees
36.55%2.17M
-53.33%77K
--0
1,154.22%2.08M
77.03%262K
--1.59M
--165K
--68K
-32.24%166K
--148K
Net other financing activities
--0
---37K
---3.39M
---3.42M
---3.15M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-97.95%2.17M
100.26%40K
52,735.03%402.66M
-27.32%87M
-105.11%-2.9M
--105.88M
---15.23M
---765K
674.91%119.69M
--56.7M
Net cash flow
Beginning cash position
-67.76%25.16M
11,078.64%77.47M
-90.62%8.27M
64.42%88.14M
-89.03%10.27M
--78.04M
--693K
--88.14M
3.27%53.61M
--93.61M
Current changes in cash
126.94%18.25M
-167.63%-52.31M
179.13%69.2M
-331.29%-79.88M
63.30%-2.01M
---67.77M
--77.35M
---87.45M
1,937.52%34.54M
---5.47M
End cash Position
322.57%43.41M
-67.76%25.16M
11,078.64%77.47M
-90.62%8.27M
-90.62%8.27M
--10.27M
--78.04M
--693K
64.42%88.14M
--88.14M
Free cash flow
-29.88%-15.92M
-49.50%-16.13M
-225.87%-26.02M
-53.19%-45.68M
-114.48%-14.65M
---12.26M
---10.79M
---7.99M
-116.84%-29.82M
---6.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.82%-15.92M-49.45%-16.12M-225.72%-26.01M-53.26%-45.68M-114.45%-14.65M-12.26M-10.79M-7.99M-118.28%-29.8M-6.83M
Net income from continuing operations -73.39%-20.41M-62.73%-18.9M-95.36%-16.93M-37.14%-48.61M-97.27%-16.56M---11.77M---11.62M---8.67M-176.06%-35.44M---8.39M
Depreciation and amortization 320.00%21K75.00%7K0.00%4K13.33%17K0.00%4K--5K--4K--4K50.00%15K--4K
Other non cash items -106.25%-4K-101.61%-10K-102.40%-3K60.90%819K-91.59%9K--64K--621K--125K26.62%509K--107K
Change In working capital 1,644.62%3.4M951.40%3.01M-2,351.74%-8.4M-22.53%3.44M98.24%2.59M--195K--286K--373K325.67%4.44M--1.3M
-Change in receivables 4,600.00%45K-------------------1K----------------
-Change in prepaid assets 76.84%-431K327.87%1.21M-2,624.11%-5.65M-353.77%-2.72M-178.06%-555K---1.86M---531K--224K153.76%1.07M--711K
-Change in payables and accrued expense 85.32%3.79M131.09%1.89M-1,920.13%-2.71M85.55%6.15M429.34%3.14M--2.04M--817K--149K2,807.02%3.31M--593K
-Change in other current assets --0---1K---33K-75.00%13K--0--13K--0--0161.18%52K--0
Cash from discontinued investing activities
Operating cash flow -29.82%-15.92M-49.45%-16.12M-225.72%-26.01M-53.26%-45.68M-114.45%-14.65M---12.26M---10.79M---7.99M-118.28%-29.8M---6.83M
Investing cash flow
Cash flow from continuing investing activities 119.83%32.01M-135.05%-36.23M-290.66%-307.44M-118.95%-121.2M128.07%15.53M-161.39M103.36M-78.7M-56,963.92%-55.35M-55.34M
Net PPE purchase and sale -83.33%1K-133.33%-14K---12K--0--0--6K---6K--085.57%-14K--1K
Net investment purchase and sale 119.83%32M-135.04%-36.22M-290.64%-307.43M-119.01%-121.2M128.07%15.53M---161.39M--103.36M---78.7M---55.34M---55.34M
Cash from discontinued investing activities
Investing cash flow 119.83%32.01M-135.05%-36.23M-290.66%-307.44M-118.95%-121.2M128.07%15.53M---161.39M--103.36M---78.7M-56,963.92%-55.35M---55.34M
Financing cash flow
Cash flow from continuing financing activities -97.95%2.17M100.26%40K52,735.03%402.66M-27.32%87M-105.11%-2.9M105.88M-15.23M-765K674.91%119.69M56.7M
Net issuance payments of debt --0--056.18%-365K---16.29M---7K---61K---15.39M---833K--0--0
Net common stock issuance --0--0--406.41M----------0--0--0--------
Net preferred stock issuance -------------12.47%104.63M--0--------------119.53M--56.55M
Proceeds from stock option exercised by employees 36.55%2.17M-53.33%77K--01,154.22%2.08M77.03%262K--1.59M--165K--68K-32.24%166K--148K
Net other financing activities --0---37K---3.39M---3.42M---3.15M--------------------
Cash from discontinued financing activities
Financing cash flow -97.95%2.17M100.26%40K52,735.03%402.66M-27.32%87M-105.11%-2.9M--105.88M---15.23M---765K674.91%119.69M--56.7M
Net cash flow
Beginning cash position -67.76%25.16M11,078.64%77.47M-90.62%8.27M64.42%88.14M-89.03%10.27M--78.04M--693K--88.14M3.27%53.61M--93.61M
Current changes in cash 126.94%18.25M-167.63%-52.31M179.13%69.2M-331.29%-79.88M63.30%-2.01M---67.77M--77.35M---87.45M1,937.52%34.54M---5.47M
End cash Position 322.57%43.41M-67.76%25.16M11,078.64%77.47M-90.62%8.27M-90.62%8.27M--10.27M--78.04M--693K64.42%88.14M--88.14M
Free cash flow -29.88%-15.92M-49.50%-16.13M-225.87%-26.02M-53.19%-45.68M-114.48%-14.65M---12.26M---10.79M---7.99M-116.84%-29.82M---6.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data